1. Participation of the elderly, women, and minorities in pivotal trials supporting 2011-2013 U.S. Food and Drug Administration approvals;Downing;Trials,2016
2. Enhancing the Diversity of Clinical Trial Populations – Eligibility Criteria, Enrollment Practices, and Trial Designs: Guidance for Industry. Silver Spring,2020
3. Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials; Guidance for Industry (Draft Guidance),2022
4. Revisions to the standards for the classification of federal data on race and ethnicity. [Document no. 97-28653, Published October 30, 1997];Fed Regist,1997
5. Updated guidance on the reporting of race and ethnicity in medical and science journals;Flanagin;JAMA,2021